Objective-Suppressors of cytokine signaling (SOCS) proteins are intracellular regulators of receptor signal transduction, mainly Janus kinase/signal transducers and activators of transcription (JAK/STAT). We investigated the effects of SOCS modulation on the JAK/STAT-dependent responses in vascular cells, and their implication in atherosclerotic plaque development. Methods and Results-Immunohistochemistry in human plaques revealed a high expression of SOCS1 and SOCS3 by vascular smooth muscle cells (VSMCs) and macrophages in the inflammatory region of the shoulders, when compared to the fibrous area. SOCS were also increased in aortic lesions from apoE Ϫ/Ϫ mice. In cultured VSMCs, endothelial cells, and monocytes, SOCS1 and SOCS3 were transiently induced by proinflammatory cytokines, proatherogenic lipoproteins, and immune molecules. Furthermore, overexpression of SOCS suppressed STAT activation and reduced inflammatory gene expression and cell growth, whereas SOCS knockdown increased these cell responses. In vivo, antisense oligodeoxynucleotides targeting SOCS3 exacerbated the atherosclerotic process in apoE Ϫ/Ϫ mice by increasing the size, leukocyte content, and chemokine expression in the lesions.
A therosclerosis is a chronic inflammatory disease that involves a complex interaction of the artery wall and its cellular components, lipoproteins, and circulating blood elements. 1 Leukocyte invasion and vascular smooth muscle cell (VSMC) proliferation are key early events in lesion development. 2 Low-density lipoproteins (LDL) and cytokines, such as interferon ␥ (IFN␥) and interleukin-6 (IL-6), influence the dynamics of vascular cell function and are main mediators of inflammation during atherogenesis. 2, 3 Native and modified forms of LDL induce a variety of biological properties, including cytokine expression, changes in monocyte/macrophages motility and arterial vasomotricity, and VSMC mitogenesis. 4, 5 IFN␥ is expressed in human and experimental plaques, and induces the expression of major histocompatibility complex-II, downregulates scavenger receptors, and modulates vascular cell proliferation. 2, 6 IL-6 is secreted from endothelial cells (ECs), VSMCs, and leukocytes, and has multiple biological activities, including lymphocyte activation, acute-phase proteins induction, and proliferation. 7, 8 Evidence supports the involvement of cellular and humoral immune responses in atherosclerosis, from its initiation to its thrombotic complication. 9 Elevated levels of LDL-containing immune complexes (ICs) and their IgG Fc receptors (Fc␥R) have been found in atherosclerotic patients. 10 Furthermore, Fc␥R mediates the clearance of ICs containing LDL and foam cell formation, 10 and Fc␥R activation in vascular cells is critical for atherosclerosis development in mice. 11 The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is an essential intracellular mechanism of cytokines and other stimuli that regulates gene expression and cellular activation, proliferation, and differentiation. 12 Cytokine receptor engagement activates the associated JAK, which phosphorylates the receptor cytoplasmic domain to allow recruitment and tyrosine phosphorylation of STAT. Activated STATs dimerize and translocate into the nucleus to activate specific gene expression. Four JAK and 7 STAT family members constitute the JAK/STAT system, and cell-specific JAK/STAT combinations have been paired with each cytokine receptor. 13 JAK/STAT pathway is controlled through different mechanisms, including receptor internalization, protein tyrosine phosphatases, and protein inhibitors of activated STAT. 14 Furthermore, suppressors of cytokine signaling (SOCS) proteins are pivotal in negative regulation of JAK/STAT. 15 SOCS comprise a family of 8 intracellular cytokine-inducible proteins (CIS, SOCS1-SOCS7), each of which has a variable N-terminal domain, a central SH2 domain, and a conserved C-terminal SOCS box involved in proteasomal targeting. 13, 15 In addition to cytokines, SOCS are induced by insulin, chemokines, angiotensin II, lipopolysaccharide, and ICs, thus indicating their involvement in many biological processes. 12, 16, 17 JAK/STAT controls important inflammatory processes in vascular cells, and its activation is involved in atherosclerosis and hypertension. 18 -22 However, the negative regulation of this pathway during vascular damage is not clearly defined. We investigated the involvement of SOCS family in atherosclerosis development, analyzing SOCS expression in human and experimental plaques, and the effects of SOCS modulation on vascular cell responses.
Methods
Please see expanded Methods in the supplemental materials (available online at http://atvb.ahajournals.org).
Reagents
Recombinant IFN␥ and IL-6, human native LDL, 23 and ICs from IgG 16 were used.
Atherosclerotic Plaques
Shoulder and fibrous cap regions of human samples from carotid endarterectomy were analyzed (nϭ22). 24 Aorta from apoE Ϫ/Ϫ and wild-type (WT) mice fed on Western diet during 24 weeks were subjected to histology and mRNA analysis. 25 Spleens were collected for mRNA expression analysis.
Histology
In human plaques, SOCS expressing cells were identified by immunofluorescence in combination with immunoperoxidase. 24, 25 Lesion areas in murine aortas were quantified by morphometry after Oil red O/hematoxylin. Macrophages (Moma2), T lymphocytes (CD4/CD8), VSMCs (␣-actin), SOCS1/3, and P-STAT1/3 were detected by immunoperoxidase. 24, 25 
Cell Cultures
VSMCs from human and mice (WT and ␥ Ϫ/Ϫ ), human mononuclear cells (THP-1 line and PBMCs), and human microvascular ECs were cultured as described. 11, [25] [26] [27] Cell proliferation was measured by methylen blue assay. 25
Protein and mRNA Expression
Proteins were immunoblotted with P-STAT1/P-STAT3, STAT1/ STAT3, and SOCS1/SOCS3. Target gene expressions in cells and tissues were analyzed by RT-PCR or real-time PCR, and normalized to GAPDH expression. 11, 16 Luciferase Assay Cells were transfected with SOCS expression vectors (S1wt, S3wt, cloned in p513HA) and STAT plasmids for luciferase reporter gene assay. 16
SOCS3 Knockdown
SOCS3 antisense and sense oligodeoxynucleotides (ODN) were transfected using polyethylenimine (PEI) reagent. 16, 17, 28 ApoE Ϫ/Ϫ mice transfected with antisense ODN (nϭ10), sense ODN (nϭ4), and controls (vehicle-injected, nϭ7) were studied after 5 weeks on atherogenic diet.
Results

SOCS Expression in Atherosclerotic Lesions
Histological examination in human plaques revealed significantly higher synthesis of SOCS1 and SOCS3 in the inflammatory region of the shoulders, as compared with the fibrous area ( Figure 1 ). Furthermore, colocalization studies identified VSMCs and macrophages as the main cell types expressing SOCS1 and SOCS3 in human lesions (supplemental Figure I) .
SOCS were also expressed in experimental atherosclerosis. As compared with WT, atherosclerosis development in apoE Ϫ/Ϫ mice was associated with increased mRNA (n-fold versus WT: SOCS1, 3.5Ϯ0.3; SOCS3, 7.0Ϯ1.9) and protein expression both in the intima and media of aortic lesions (supplemental Figure II) .
JAK/STAT Activation in Cultured Cells
JAK/STAT pathway was analyzed in the main cell types present in the plaque (VSMCs, monocytes, and ECs) under 3 different stimulatory conditions, mimicking different responses involved in atherogenesis: proinflammatory cytokines (IL-6/IFN␥), proatherogenic lipoproteins (LDL), and immune molecules (ICs). Cytokines, LDL, and ICs timedependently induced STAT1 and STAT3 tyrosine phosphorylation in murine VSMCs (supplemental Figure III) . In human VSMCs, STAT1 and STAT3 were also rapidly activated by cytokines, whereas the response in human ECs occurred at later time points. By contrast, STAT1 phosphorylation precedes STAT3 in human PBMC. The STAT phosphorylation correlated with increased transcriptional activity of STAT-driven plasmids, both in VSMCs and monocytes incubated with cytokines, LDL or ICs (supplemental Figure III ).
SOCS Expression in Vascular Cells
SOCS proteins were time-dependently induced by IL-6/IFN␥ in murine VSMCs (Figure 2A ). SOCS3 synthesis was maximal at 4 hours and then decreased to baseline, whereas SOCS1 was expressed later and remained increased even after 24 hours. SOCS proteins were also rapid and transiently induced by LDL ( Figure 2B ), being SOCS3 earlier expressed.
Consistent with the protein kinetics, incubation of VSMCs, monocytes, and ECs with cytokines rapidly increased SOCS3 mRNA expression, whereas SOCS1 expression was delayed ( Figure 2D and supplemental Figure IV ). SOCS3 mRNA levels were unmodified by cycloheximide preincubation (2.2Ϯ0.3 versus 2.3Ϯ0.2, fold increase at 2 hours, nϭ2), excluding de novo protein synthesis for SOCS gene induction.
SOCS3 expression also preceded SOCS1 induction in IC-stimulated VSMCs. Furthermore, the Fc␥R involvement was assessed in cells from mice deficient in the common ␥-chain for signaling and functionality of Fc␥RI and III. 11, 29 VSMCs from ␥ Ϫ/Ϫ mice failed to respond to ICs, as shown by impaired SOCS expression ( Figure 2C and supplemental Figure IV) . 
SOCS Prevent STAT-Mediated Responses in Vascular Cells
Transfection with SOCS expression vectors (S1wt and S3wt) in murine VSMCs and THP-1 monocytes prevented the cytokine-induced STAT phosphorylation and reporter activity (Figure 3A and 3B; supplemental Table I ). SOCS overexpression also reduced the mitogenic effect of IL-6 and LDL on murine VSMCs ( Figure 3C ) and the growth of cytokinestimulated THP-1 monocytes (% versus stimulus: S1wt, 70Ϯ10; S3wt, 66Ϯ9; PϽ0.05). Furthermore, SOCS prevented the gene expression of MCP-1 and ICAM-1 in murine VSMCs ( Figure 3D) . These results implicate SOCS as negative regulators of STAT-mediated inflammatory responses in vascular cells.
Effects of SOCS3 Inhibition In Vitro and In Vivo
Knockdown studies were done using antisense ODN, which were designed to hybridize to SOCS3 mRNA at the translation start site, blocking translation and leading to decreased protein expression. 16, 17 Antisense ODN, but not sense, dose-dependently decreased SOCS3 synthesis in cytokinestimulated cells. Furthermore, SOCS3 downregulation enhanced the STAT1 activation and the mitogenic effect of cytokines in VSMCs and monocytes ( Figure V) .
To ascertain the role of SOCS3 in vivo, antisense ODN were delivered to apoE Ϫ/Ϫ by using the nonviral vector PEI. This transfection reagent increases the stability of unmodified ODN in plasma, enhances their uptake, and protects against nuclease degradation. 30 To validate the gene transfer method, FITC-conjugated antisense ODN were injected into atherosclerotic mice. After 4 hours, green fluorescence was distributed in many tissues, including the aortic lesion ( Figure 4A ).
The functional consequences of endogenous SOCS3 depletion were further explored in apoE Ϫ/Ϫ mice fed on atherogenic diet for 5 weeks. Immunostaining revealed a significant decrease of SOCS3 protein in aorta from antisense ODN, compared with vehicle and sense ODN mice. As a consequence, STAT1/STAT3 activation (assessed by P-STAT1/P-STAT3 nuclear staining) was increased in antisense ODN group (Figure 4) . Moreover, lesion area quantification indicated that the size and extension along the aorta were higher in antisense ODN-transfected mice ( Figure 5A and 5B) .
We further investigated the impact of reduced SOCS3 on the presence of leukocytes (macrophages and T lymphocytes) and VSMCs, integral cellular components of the plaque. SOCS3 knockdown significantly increased the content of VSMCs (␣-actin), macrophages (Moma2), and CD4 ϩ , but not CD8 ϩ lymphocytes within the lesions ( Figure 5A and 5C ), and the aortic chemokine gene expression (RANTES mRNA, arbitrary units: vehicle, 1.3Ϯ0.2; sense, 1.7Ϯ0.2, antisense, 4.0Ϯ0.9, PϽ0.05).
To assess whether SOCS3 suppression affects the systemic response to atherosclerosis, we analyzed spleens for the presence of Th1 cytokines (TNF␣ and IFN␥), Th2 cytokine (IL-10), and Th3 cytokine (TGF␤). Antisense ODN transfection significantly increased the mRNA expression of these cytokines ( Figure 5D ).
There were no statistically significant differences in lesion size, cell content, and cytokine expression between the vehicle and sense ODN groups.
Discussion
JAK/STAT is an important signaling pathway regulating the initiation/progression of atherosclerosis and the remodeling in response to injury. 18, 19 Because excessive inflammation tips the balance toward progression of atherogenesis, strategies that prevent harmful response to cytokines would be of potential benefit. In this article we ascertain the involvement of negative regulators SOCS in vascular homeostasis, analyzing whether SOCS modulation affects the JAK/STATdependent cell responses during atherosclerosis. We provide first evidence that SOCS1 and SOCS3 are highly expressed in the shoulder region of human carotid plaques, colocalizing with VSMCs and macrophages. This vulnerable region is characterized by macrophage accumulation and inflammatory gene expression, such as MCP-1, IL-6, and angiotensin II, 8, 24 all of them known inducers of JAK/STAT in vascular cells. We also demonstrate an increased expression of SOCS in aortic lesions from apoE Ϫ/Ϫ mice, in agreement with a recent report on SOCS in developing atherosclerosis. 30 JAK/STAT activation have been previously found in atherosclerotic lesions, 20, 31, 32 and in vascular cells incubated with cytokines, angiotensin II, and lipids. 19, 31, [33] [34] [35] The important role of STAT1-mediated macrophage apoptosis and foam cell formation in atherosclerotic lesion development has been recently reported. 21, 22 Consistent with this, we demonstrate STAT1 and STAT3 activation in cultured vascular cells under inflammatory, atherogenic, and immune stimulation. Along with STAT activation, SOCS were rapid and transiently induced in VSMCs, monocytes, and ECs, SOCS3 expression always preceding SOCS1 induction. It has been described that both SOCS1 and SOCS3 can regulate IFN␥/ STAT1 and IL-6/STAT3 signaling in different cells. 36 SOCS3 desensitizes cells rapidly, whereas SOCS1-mediated desensitization to cytokines occurred at later time points. 37 This phenomenon could represent a dual negative regulatory system of the SOCS in vascular cells: SOCS3 first modulating the STAT-mediated inflammatory response and SOCS1 as a regulator of activated pathways after longer exposition to inflammatory stimuli. A model for this kinetics is proposed in the supplemental Figure VI .
It is noteworthy that, in addition to cytokines, SOCS are associated with Fc␥R stimulation in VSMCs and monocytes, as previously described in other cells. 16 The importance of immune activation during atherogenesis is a rising concept in the last years, and evidence suggests that LDL-containing ICs are involved in this process. 9, 10 Furthermore, increased Fc␥R expression has been found in plaques and leukocytes from atherosclerotic patients, 38 and Fc␥R deficiency protects against atherosclerosis in mice. 11 Our study demonstrates that SOCS represses IC-induced STAT activation, and extends the concept that SOCS have more diverse functions than simply acting as negative regulators of cytokine receptor signaling in vascular cells.
VSMC proliferation is an important pathogenic mechanism in atherosclerosis, and JAK/STAT activation mediates the mitogenic actions of IL-6, growth factors, angiotensin II, and LDL. 5, 33, 34, 39 Consistent with this, we observed that SOCS overexpression prevents proliferation in VSMCs and monocytes, whereas SOCS3 inhibition led to an increase in the magnitude of cytokine responses. Furthermore, we show that atherogenic levels of native LDL induce STAT activation and cell growth in VSMCs. The molecular mechanisms by which nonoxidized native LDL affects vascular homeostasis include vasoconstriction, intracellular calcium influx, oxidative stress, and cytokine production. 5, 35, 39 To our knowledge, we are the first in describing the SOCS induction by LDL in VSMCs and the role of SOCS as negative modulators of LDL-induced cell responses.
In addition to cell proliferation, SOCS blunted the vascular expression of MCP-1 and ICAM-1, genes involved in the recruitment of monocytes to the intima during atherogenesis. MCP-1 and ICAM-1 expression has been associated with development of vascular diseases, and their inhibition markedly decreases plaque formation. 40, 41 Our data are compatible with that, suggesting that the compensatory effect of SOCS may be in part mediated by the suppression of chemokines and adhesion molecules.
SOCS family controls the magnitude and duration of JAK/STAT signaling through several mechanisms, including receptor interaction, direct JAK inhibition, STAT binding, and targeting receptor complex, and other signaling proteins for proteasomal degradation. 12, 13, 15 In this study, forced expression of SOCS1 and SOCS3 prevents the STAT activation by cytokines, LDL, and ICs, thus unveiling the importance of this pathway in vascular cells responses. However, we cannot discard that other mechanisms, such as the constitutive inhibitors protein tyrosine phosphatases and protein inhibitors of activated STAT, 14, 34 may act either in conjunction or independently in controlling JAK/STAT pathway in vascular cells.
Evidence is emerging for the involvement of SOCS in inflammatory diseases, such as rheumatoid arthritis, cerebral ischemia, heart failure, Crohn disease, hypertension, and renal injury. 12,15 SOCS1/SOCS3 inhibition, leading to sustained cytokine activation of STAT, contributes to the progression of chronic inflammatory diseases, 17, 42, 43 whereas SOCS3 expression suppressed inflammation in mouse arthritis. 12, 44, 45 Consistent with this, we found greater plaques and higher content of macrophages, CD4 ϩ T lymphocytes and VSMCs in the aortas of antisense ODN mice, which suggests a role of SOCS3 in limiting leukocyte infiltration and VSMCs migration/proliferation during the atherogenic processes. Although one single knockdown would be not sufficient for a total downregulation of SOCS3 during this entire time frame, our results demonstrate that effective SOCS3 inhibition in the initial stages of atherosclerosis sustained STAT1/STAT3 activation and aggravates lesion development.
Adaptive T cell immune responses play a significant role in atherogenesis. Th1 cells are the primary effector T cells influencing atherosclerosis, 2 although severe hypercholesterolemia is associated with a Th1/Th2 switch of the autoimmune response in apoE Ϫ/Ϫ mice. 2, 6 In this study, antisense ODN significantly increased the splenic gene expression of proinflammatory cytokines TNF␣ and IFN␥ (Th1 subset), the antiinflammatory cytokine IL-10 (Th2), and the Th3 cytokine TGF␤ (Th1/Th2 regulator). These findings indicate that SOCS3 suppression accelerates lesion development without affecting systemic Th1/Th2 balance in cholesterol dietinduced atherosclerosis.
On the whole, we report that SOCS are critical modulators of inflammatory processes within the atherosclerotic vascular wall. Activation of this endogenous antiinflammatory pathway might be a therapeutic strategy for treating cardiovascular diseases.
